Previous studies have reported that age ≥ 55, advanced disease stage, hormonally active ACC, RX/R1 status, Ki67 proliferative index, recurrence-free survival, and adjuvant mitotane treatment were independently associated with OS [25, 26]. The gene discussed is MKI67; the disease is adrenal cortex carcinoma.